Investigation for the protective effects and mechanism of lipid metabolism regulation and metabolites on retinopathy of prematurity

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900026344

Enrollment

Unknown

Registered

2019-10-01

Start date

2019-10-01

Completion date

Unknown

Last updated

2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

retinopathy of prematurity

Interventions

ROP group:no

non-ROP group:no

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: for premature and low-birth-weight infants whose birth weight was <2000g, or whose gestational age was <32 weeks, initial screening began at 4-6 weeks postnatal or 31-32 weeks gestational age correction.

Exclusion criteria

Exclusion criteria: 1. Premature infant who could not tolerate the examination; 2. the first screening time was more than 4-6 weeks after birth or 32 weeks of correct gestational age.

Design outcomes

Primary

Measure	Time frame
Omega-3 long-chain polyunsaturated fatty acids;	—

Secondary

Measure	Time frame
LDL-C;HDL-C;TC;TG;	—

Countries

China

Contacts

Public ContactYan Gong

Zhongnan Hospital of Wuhan University

yan.gong@whu.edu.cn+86 13971533512

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026